Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.1.9
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Consolidated Statements Of Operations    
Revenues      
Operating expenses:    
Amortization & depreciation 776us-gaap_DepreciationAndAmortization 777us-gaap_DepreciationAndAmortization
General and administrative 505,552us-gaap_GeneralAndAdministrativeExpense 783,848us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 506,328us-gaap_OperatingExpenses 784,625us-gaap_OperatingExpenses
Loss from operations (506,328)us-gaap_OperatingIncomeLoss (784,625)us-gaap_OperatingIncomeLoss
Other income (expense):    
Gain/(Loss) on fair value adjustment - derivatives (21,559)IMLE_LossOnFairValueAdjustmentDerivatives 186,202IMLE_LossOnFairValueAdjustmentDerivatives
Gain on debt reversal    99,805us-gaap_GainLossOnNonRecourseDebt
Interest expense (188,046)us-gaap_InterestIncomeExpenseNet (170,428)us-gaap_InterestIncomeExpenseNet
Interest expense - beneficial conversion feature (32,996)us-gaap_InterestExpense (94,161)us-gaap_InterestExpense
Total other income (expense) (242,601)us-gaap_NonoperatingIncomeExpense 21,418us-gaap_NonoperatingIncomeExpense
Loss before provision for income taxes (748,929)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (763,207)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Provision for income tax      
Net loss (748,929)us-gaap_ProfitLoss (763,207)us-gaap_ProfitLoss
Less: Net loss attributable to noncontrolling interest 4,367us-gaap_NetIncomeLossAttributableToNoncontrollingInterest 4,791us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
Net loss attributable to TranBioTec, Inc. $ (744,562)us-gaap_NetIncomeLoss $ (758,416)us-gaap_NetIncomeLoss
Net loss per share    
(Basic and fully diluted) $ (0.02)us-gaap_EarningsPerShareBasicAndDiluted $ (0.02)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average number of common shares outstanding 39,215,919IMLE_WeightedAverageNumberOfCommonSharesOutstanding 32,540,568IMLE_WeightedAverageNumberOfCommonSharesOutstanding